Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 1.00 |
| ▸ | CA4 | P22748 | 5/20 | 1.00 |
| ▸ | CA7 | P43166 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | TYR | P14679 | 1/20 | 1.00 |
| ▸ | CA2 | P00918 | 4/20 | 0.86 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.84 |
| ▸ | P4HB | P07237 | 4/20 | 0.70 |
| ▸ | ACHE | P22303 | 1/20 | 0.70 |
| ▸ | RPS6KA3 | P51812 | 3/20 | 0.69 |
| ▸ | POLB | P06746 | 3/20 | 0.67 |
| ▸ | GAA | P10253 | 3/20 | 0.67 |
| ▸ | APEX1 | P27695 | 2/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.67 |
| ▸ | XDH | P47989 | 2/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | CBS | P35520 | 1/20 | 0.66 |
| ▸ | NQO2 | P16083 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tiliroside SCHEMBL28142584 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL12568488 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL29366630 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL23598 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL13963382 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL16131015 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL31082442 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL12568460 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL15756208 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| SCHEMBL18922182 | 0.96 | CA12 (0.93) | CA12CA4CA7CYP3A4TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 549 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743181-A1 | POLYPHENOL-RICH DAMASK ROSE EXTRACT DERIVED FROM A HYDRODISTILLATION BYPRODUCT AND ITS USES AS A FOOD SUPPLEMENT | Robertet S.A. (FR) | 2026-05-20 | — | — | EP | claimed |
| US-12419317-B1 | Plant derived food preservative | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2025-09-23 | — | — | US | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| CN-120189494-A | Use of adiponectin and adiponectin receptor agonists for the treatment of amyotrophic lateral sclerosis | 河北医科大学第二医院 | 2025-06-24 | — | — | CN | claimed |
| CN-119949504-A | China hemp peptide nutrition protein powder and preparation method thereof | 天之草健康科技(长沙)有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119335091-A | High performance liquid chromatography detection method for simultaneously measuring 14 polyphenols | 劲牌有限公司 | 2025-01-21 | — | — | CN | claimed |
| WO-2025011789-A1 | POLYPHENOL-RICH DAMASK ROSE EXTRACT DERIVED FROM A HYDRODISTILLATION BYPRODUCT AND ITS USES AS A FOOD SUPPLEMENT | ROBERTET S.A. (FR) | 2025-01-16 | — | — | WO | claimed |
| WO-2024258363-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | SAHIN FIKRET (TR) | 2024-12-19 | — | — | WO | claimed |
| CN-117084979-B | Preparation and application of pickering multiple emulsion with stable phytosterol/chitosan composite particles | 江南大学 | 2024-12-06 | — | — | CN | claimed |
| CN-118903174-A | Application of tiliroside in preparation of medicines for treating atherosclerosis | 西南医科大学附属医院 | 2024-11-08 | — | — | CN | claimed |
| US-20080193569-A1 | Extraction Method for Producing Plant Extracts, Especially Waltheria Paniculata Extracts Containing Tiliroside | MERCK PATENT GESELLSCHAFT (DE) | 2008-08-14 | — | — | US | claimed |
| US-20080044502-A1 | USE OF AN AQUEOUS OR HYDROALCOHOLIC EXTRACT OF BAUHINIA FOR THE PREPARATION OF A COMPOSITION | WIRTH CORINNA | 2008-02-21 | — | — | US | claimed |
| EP-1363594-B1 | COSMETIC FORMULATIONS CONTAINING FLAVONOID DERIVATIVES | MERCK PATENT GMBH (DE) | 2007-11-21 | — | — | EP | claimed |
| EP-1393733-B1 | Use of flavonoid-derivatives for the treatment of atopic eczema | MERCK PATENT GMBH (DE) | 2006-08-23 | — | — | EP | claimed |
| US-20050019426-A1 | For care, protection from aging of skin and hair, use in treatment of various skin disorders such as leukoplakia, eczema, keratosis, psoriasis, or to promote wound healing | MERCK PATENT GMBH (DE) | 2005-01-27 | — | — | US | claimed |
| US-20040081675-A1 | Cosmetic formulations containing flavonoid derivatives | MERCK PATENT GMBH (DE) | 2004-04-29 | — | — | US | claimed |
| US-20040053860-A1 | Flavonoid derivatives for the treatment of eczema | MERCK PATENT GMBH (DE) | 2004-03-18 | — | — | US | claimed |
| EP-1393733-A1 | Flavonoid-derivate for the treatment of eczema | MERCK PATENT GmbH (DE) | 2004-03-03 | — | — | EP | claimed |
| US-6471973-B2 | DRUGS, COSMETICS, DIETETICS, AGRICULTURE | COLETICA (FR) | 2002-10-29 | — | — | US | claimed |
| US-20010031735-A1 | Flavonoide esters and their use notably in cosmetics | COLETICA (FR) | 2001-10-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010031735-A1 | Flavonoide esters and their use notably in cosmetics | TYR, MITF, CYP2F1 | CA12 1957/4885CA4 948/4885CA7 932/4885 |
| US-20040081675-A1 | Cosmetic formulations containing flavonoid derivatives | TYR, MITF, TEAD3 | CA12 4880/4885CA4 4790/4885CA7 4827/4885 |
| US-20040053860-A1 | Flavonoid derivatives for the treatment of eczema | TSLP, CYP51A1, TYR | CA12 4787/4885CA4 4516/4885CA7 4491/4885 |
| US-20050019426-A1 | For care, protection from aging of skin and hair, use in treatment of various skin disorders such as leukoplakia, eczema, keratosis, psoriasis, or to promote wound healing | ITCH, CUTA, POLR1C | CA12 4407/4885CA4 3659/4885CA7 3419/4885 |
| US-20080193569-A1 | Extraction Method for Producing Plant Extracts, Especially Waltheria Paniculata Extracts Containing Tiliroside | MITF, FZD7, LSS | CA12 3680/4885CA4 2108/4885CA7 1373/4885 |
| US-20080044502-A1 | USE OF AN AQUEOUS OR HYDROALCOHOLIC EXTRACT OF BAUHINIA FOR THE PREPARATION OF A COMPOSITION | BROX, HAAO, HIRA | CA12 2398/4885CA4 1551/4885CA7 1036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.